Erratum: preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study
- PMID: 25879441
- PMCID: PMC4372227
- DOI: 10.1186/s12885-015-1181-5
Erratum: preoperative chemosensitivity testing as predictor of treatment benefit in adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study
Erratum for
-
Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.BMC Cancer. 2013 Apr 12;13:190. doi: 10.1186/1471-2407-13-190. BMC Cancer. 2013. PMID: 23587148 Free PMC article.
References
-
- Alain H, Vassilis G, Amelie D, Marianne P, Hazem El M, Camilo G, Marc P, Lieven A, Caroline V, Marion M, Ivan B, Damien D, Ghislain H, Michael F, Ahmad A, Martine P, Jean-Luc Van L, Patrick F. Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study. BMC Cancer. 2013;13:190. doi: 10.1186/1471-2407-13-190. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
